Literature DB >> 18682755

Complications after colorectal anastomosis in a patient with metastatic rectal cancer treated with systemic chemotherapy and bevacizumab.

Amine Akkouche1, Lucas Sidéris, Guy Leblanc, Yves-E Leclerc, Petro Vafiadis, Pierre Dubé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18682755      PMCID： PMC2496595     

Source DB:  PubMed          Journal:  Can J Surg        ISSN： 0008-428X            Impact factor:   2.089


× No keyword cloud information.
  3 in total

1.  Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab.

Authors:  Frank A Scappaticci; Louis Fehrenbacher; Thomas Cartwright; John D Hainsworth; William Heim; Jordan Berlin; Fairooz Kabbinavar; William Novotny; Somnath Sarkar; Herbert Hurwitz
Journal:  J Surg Oncol       Date:  2005-09-01       Impact factor: 3.454

2.  The natural history of liver metastases from colorectal cancer.

Authors:  P Luna-Perez; D F Rodriguez-Coria; B Arroyo; J Gonzalez-Macouzet
Journal:  Arch Med Res       Date:  1998       Impact factor: 2.235

3.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245
  3 in total
  3 in total

Review 1.  Late anastomotic breakdown with bevacizumab in colorectal cancers, a case-based review.

Authors:  T O'Hare; R McDermott; R Hannon
Journal:  Ir J Med Sci       Date:  2017-08-29       Impact factor: 1.568

Review 2.  Role of bevacizumab in colorectal cancer growth and its adverse effects: a review.

Authors:  Efstathios T Pavlidis; Theodoros E Pavlidis
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

3.  Bevacizumab-associated intestinal perforation and perioperative complications in patients receiving bevacizumab.

Authors:  Toshiaki Yoshimoto; Kozo Yoshikawa; Jun Higashijima; Tomohiko Miyatani; Takuya Tokunaga; Masaaki Nishi; Chie Takasu; Hideya Kashihara; Yukako Takehara; Mitsuo Shimada
Journal:  Ann Gastroenterol Surg       Date:  2020-02-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.